Exalys Therapeutics
Creating breakthrough anti-inflammatory therapeutics to address urgent medical needs, starting with the prevalent postoperative delirium in older patients.
General Information
BounceWatch is an independent company data service, not affiliated with Exalys Therapeutics. To contact Exalys Therapeutics, visit exalystx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Exalys Therapeutics compare?
A PDF of Exalys Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Exalys Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Exalys Therapeutics
Business keywords: anti-inflammatory therapeutics, medical innovation, postoperative delirium, older patients, novel treatments, unmet medical needs, drug development, health outcomes, surgical complications, pharmaceutical research, disease treatment, therapeutic options, healthcare advancements
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $15.00M | 2 |
|
16 Jul 2020 |
Exalys Therapeutics Alternatives & Competitors
View All Alternatives
Transformative Therapy! Innovation for global patients.
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient outcomes in c...
What if you could predict molecules to make the cause of disease disappear?
FAQ About Exalys Therapeutics
Source: BounceWatch company record for Exalys Therapeutics, https://bouncewatch.com/company/exalys-therapeutics, updated 27 December 2024. When citing, please name BounceWatch and link this page.
